1223158-00-6

Basic information

• Product Name: trans-benzyl 3-aminocyclohexylcarbamate
• Synonyms: trans-benzyl 3-aminocyclohexylcarbamate;Benzyl (trans-3-aMinocyclohexyl)carbaMate
• CAS NO: 1223158-00-6
• Molecular Formula: C14H20N2O2
• Molecular Weight: 248.3208
• Mol File: 1223158-00-6.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 409.5±44.0 °C(Predicted)
• Appearance: /
• Density: 1.13
• PKA: 12.20±0.40(Predicted)
• CAS DataBase Reference: trans-benzyl 3-aminocyclohexylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: trans-benzyl 3-aminocyclohexylcarbamate(1223158-00-6)
• EPA Substance Registry System: trans-benzyl 3-aminocyclohexylcarbamate(1223158-00-6)

Safety Data

• Hazardous Substances Data: 1223158-00-6(Hazardous Substances Data)

Usage

General Description

Trans-benzyl 3-aminocyclohexylcarbamate is a chemical compound that belongs to the class of carbamate compounds. It is often used as a building block in organic synthesis and can be utilized as a pharmaceutical intermediate in the production of various drugs. trans-benzyl 3-aminocyclohexylcarbamate has potential applications in the field of medicinal chemistry, particularly in the development of new therapeutic agents. Its structure contains a benzyl group, an aminocyclohexyl group, and a carbamate functional group, which gives it unique properties and reactivity. Due to its diverse applications and reactivity, trans-benzyl 3-aminocyclohexylcarbamate is a valuable compound in the field of chemical and pharmaceutical research and development.

Upstream product

• 100-51-6 benzyl alcohol 
• 222530-39-4 (1R,3S)-3-(tert-butoxycarbonylamino)aminocyclohexanecarboxylic acid 
• 1223158-00-6 benzyl cis-3-(aminocyclohexyl)carbamate 
• 498532-32-4 C₆H₁₄N₂*2ClH 
• 3385-21-5 1,3-diaminocyclohexane 
• 1261225-48-2 [3-(1S,3R)-benzyloxycarbonylaminocyclohexyl]-1-carbamic acid tertbutyl ester 
• 218772-92-0 (±)-cis-3-((tert-butoxycarbonyl)amino)cyclohexanecarboxylic acid 
• 501-53-1 benzyl chloroformate 
• 53084-60-9 ethyl (1R,3S)-3-aminocyclohexanecarboxylate 
• 1259278-11-9 benzyl N-[(1S,3R)-3-carbamoylcyclohexyl]carbamate 
• 952616-39-6 (1R,3S)-3-(((benzyloxy)carbonyl)amino)cyclohexanecarboxylic acid 
• 1259278-09-5 ethyl (1R,3S)-3-benzyloxycarbonylaminocyclohexane-1-carboxylate 
• 227783-08-6 (1S,3R)-3-ethoxycarbonylcyclohexane-1-carboxylic acid 

Downstream Products

• 1261225-50-6 benzyl [(1S,3R)-3-(3-methyl-4H-1,2,4-triazol-4-yl)cyclohexyl]carbamate 
• 1261225-52-8 benzyl {(1S,3R)-3-[3-methyl-5-(trifluoromethyl)-4H-1,2,4-triazol-4-yl]cyclohexyl}carbamate 

Relevant articles and documents

COMPOUNS, COMPOSITIONS AND METHODS OF USE

Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.

HETEROCYCLIC INDOLES FOR USE IN INFLUENZA VIRUS INFECTION

The current invention relates to a compound of formula (I) which can be used for the treatment of, or against viral influenza infections.

INHIBITORS OF INFLUENZA VIRUSES REPLICATION

PROBLEM TO BE SOLVED: To provide inhibitors of influenza virus replication. SOLUTION: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient comprise administering to the biological sample or patient an effective amount of a compound represented by structural formula (I) or a pharmaceutically acceptable salt thereof, where the values of structural formula (IA) are as described herein. A compound is represented by structural formula (IA) or a pharmaceutically acceptable salt thereof, where the values of structural formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle. COPYRIGHT: (C)2015,JPO&INPIT